Amman: Jordan Food and Drug Administration (JFDA) underlined the importance of administering intravenous iron infusions under medical supervision to ensure "correct" dosage and prevent potential health complications, primarily allergic reactions that may require emergency procedures due to the rare but serious risk to life. In a statement issued Sunday, the JFDA detailed that allergic reactions can surface as mild symptoms, mainly skin rash, itching, redness, a feeling of warmth or tingling, slight swelling in the face or hands, shortness of breath or wheezing, while the acute symptoms can involve anaphylactic shock, mainly severe difficulty in breathing, rapid or irregular heartbeat, and significant drops in blood pressure. The JFDA advised people, who suffered these symptoms after receiving an iron infusion, should immediately seek medical attention at the nearest hospital or emergency center. Source: Jordan News Agency
JFDA Advises Medical Supervision for Iron infusions to Avoid Health Risks
RECENT POST
UAE Minister Welcomes US Efforts for Peace in Sudan
September 23, 2026
Al Ain Hosts Inaugural Future Business Forum
September 23, 2026
ADIPEC 2026 to Mobilize Global Energy Leaders in Abu Dhabi
September 23, 2026
Space42 and Telespazio Ib©rica Launch Wildfire-Monitoring Mission in Spain
September 23, 2026